Neuromedin U receptor 1

From WikiMD's Medical Encyclopedia

Revision as of 21:15, 13 April 2024 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Neuromedin U receptor 1 (NMUR1) is a protein that in humans is encoded by the NMUR1 gene. It is a G protein-coupled receptor (GPCR) that plays a critical role in the regulation of several physiological processes, including stress response, energy homeostasis, pain, and gastrointestinal motility. NMUR1, along with its counterpart NMUR2, mediates the effects of the neuropeptide Neuromedin U (NMU), which is named for its potent contractile effects on the uterus and is widely distributed in various tissues including the gastrointestinal tract, central nervous system, and adipose tissue.

Function

NMUR1 is predominantly expressed in peripheral tissues, with high levels found in the lungs, kidneys, and adrenal glands, suggesting its involvement in the regulation of blood pressure, fluid balance, and adrenal gland function. The receptor is activated by NMU, leading to a series of intracellular events through the activation of G proteins. This activation results in the modulation of adenylate cyclase activity, leading to changes in cAMP levels and subsequent activation of protein kinase A (PKA). The signaling pathways engaged by NMUR1 influence various physiological responses, including the modulation of feeding behavior, energy expenditure, and inflammatory responses.

Clinical Significance

The role of NMUR1 in regulating energy balance and metabolism makes it a potential target for the development of treatments for obesity and metabolic syndrome. Additionally, because NMU and its receptors are involved in the stress response and pain perception, NMUR1 could be a target for developing new analgesics or treatments for stress-related disorders.

Genetics

The NMUR1 gene is located on chromosome 2 in humans. Variations in this gene may influence individual differences in body weight regulation and susceptibility to metabolic disorders. Research into the genetic aspects of NMUR1 and its interactions with NMU could provide insights into personalized medicine approaches for treating obesity and related conditions.

Pharmacology

Understanding the pharmacology of NMUR1 is crucial for developing drugs that can modulate its activity. Agonists that activate NMUR1 could potentially be used to treat conditions like weight loss or appetite suppression, whereas antagonists might be useful in treating conditions associated with excessive NMU signaling, such as certain types of inflammation or hypertension.

See Also


Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!



Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.